Startseite Evaluation of the Bio-Rad VARIANT™ II HbA 2/HbA 1C Dual Program for measurement of hemoglobin concentrations and detection of variants
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Evaluation of the Bio-Rad VARIANT™ II HbA 2/HbA 1C Dual Program for measurement of hemoglobin concentrations and detection of variants

  • Jean Riou , Christian Godart , Mireille Mathis , Didier Hurtrel , Henri Wajcman , Claude Préhu und Josiane Bardakdjian
Veröffentlicht/Copyright: 21. September 2011
Veröffentlichen auch Sie bei De Gruyter Brill

Abstract

In this work data obtained on the VARIANT™ II hemoglobin analyzer using the Dual Kit elution system were compared to those obtained with the β-Thalassemia Short Program. Since many laboratories still use an earlier model of the hemoglobin analyzer, the Variant™ 1, these data were also compared to those obtained with the latter instrument. Our study is divided into two parts. The first is an evaluation of the precision of the VARIANT™ II for determining the levels of hemoglobin (Hb)A 2 and Hb F. This was carried out for normal subjects, thalassemic patients and patients with HbS. The second part concerns the potential of this instrument in the presumptive identification of Hb variants.


Corresponding author: Josiane Bardakdjian, Service de Biochimie Génétique, Hôpital Henri Mondor, 51 Avenue du Maréchal de Lattre de Tassigny, 94010 Créteil, France Phone: +33-1-49812848, Fax: +33-1-49812851, e-mail:

References

1 Riou J, Godart C, Hurtrel D, Mathis M, Bimet C, Bardakdjian-Michau J, et al. Cation-exchange HPLC evaluated for presumptive identification of hemoglobin variants. Clin Chem 1997; 43: 34–9. 10.1093/clinchem/43.1.34Suche in Google Scholar

2 Moridani MY, Verjee Z, Allen LC. Analytical evaluation of hemoglobin A(1c) dual kit assay on Bio-Rad Variant II: an automated HPLC hemoglobin analyzer for the management of diabetic patients. Clin Biochem 2003; 36: 317–20. 10.1016/S0009-9120(03)00013-4Suche in Google Scholar

3 Higgins TN, Blakney GB, Dayton J. Analytical evaluation of the Bio-Rad variant II automated HbA(1C) analyzer. Clin Biochem 2001; 34: 361–5. 10.1016/S0009-9120(01)00229-6Suche in Google Scholar

4 Lahousen T, Roller RE, Lipp RW, Schnedl WJ. Silent haemoglobin variants and determination of HbA(1c) with the HPLC Bio-Rad Variant II. J Clin Pathol 2002; 55: 699–703. 10.1136/jcp.55.9.699Suche in Google Scholar PubMed PubMed Central

5 Lafferty JD, McFarlane AG, K Chui DH. Evaluation of a dual hemoglobin A(2)/A(1c) quantitation kit on the bio-rad variant II automated hemoglobin analyzer. Arch Pathol Lab Med 2002; 126: 1494–500. 10.5858/2002-126-1494-EOADHASuche in Google Scholar PubMed

6 Joutovsky A, Hadzi-Nesic J, Nardi MA. HPLC retention time as a diagnostic tool for hemoglobin variants and hemoglobinopathies: a study of 60000 samples in a clinical diagnostic laboratory. Clin Chem 2004; 50: 1736–47. 10.1373/clinchem.2004.034991Suche in Google Scholar PubMed

7 Wajcman H, Prehu C, Bardakdjian-Michau J, Prome D, Riou J, Godart C, et al. Abnormal hemoglobins: laboratory methods. Hemoglobin 2001; 25: 169–81. 10.1081/HEM-100104026Suche in Google Scholar PubMed

8 Joutovsky A, Nardi M. Hemoglobin C and hemoglobin O-Arab variants can be diagnosed using the Bio-Rad Variant II high-performance liquid chromatography system without further confirmatory tests. Arch Pathol Lab Med 2004; 128: 435–9. 10.5858/2004-128-435-HCAHOVSuche in Google Scholar PubMed

Received: 2004-9-8
Accepted: 2004-10-25
Published Online: 2011-9-21
Published in Print: 2005-4-1

©2005 by Walter de Gruyter Berlin New York

Artikel in diesem Heft

  1. Quality control for SELDI analysis
  2. Immunobead multiplex RT-PCR detection of carcinoembryonic genes expressing cells in the blood of colorectal cancer patients
  3. Optimization and evaluation of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS) with reversed-phase protein arrays for protein profiling
  4. Simultaneous determination of HIV antibodies, hepatitis C antibodies, and hepatitis B antigens in dried blood spots –a feasibility study using a multi-analyte immunoassay
  5. Hematopoietic cytokines in the sera of patients with pancreatic cancer
  6. Modulation of translation factor's gene expression by histone deacetylase inhibitors in breast cancer cells
  7. Whole genome amplification of buccal cell DNA: genotyping concordance before and after multiple displacement amplification
  8. Y-Chromosome short tandem repeat (STR) haplotypes in a Campania population sample
  9. TaqMan assays for genotyping of single nucleotide polymorphisms present at a disease susceptibility locus on chromosome 6
  10. The secretion of ibuprofen metabolites interferes with the capillary chromatography of urinary homovanillic acid and 4-hydroxy-3-methoxymandelic acid in neuroblastoma diagnosis
  11. Selective measurement of HCHO in urine using direct liquid-phase fluorimetric analysis
  12. A spectrophotometric micromethod for determining erythrocyte protoporphyrin-IX in whole blood or erythrocytes
  13. Simultaneous analysis of MDR1 C3435T, G2677T/A, and C1236T genotypes by multiplexed mutagenically separated PCR
  14. Measurement of reticulocyte and red blood cell indices in patients with iron deficiency anemia and β-thalassemia minor
  15. Chitotriosidase activity in colostrum from African and Caucasian women
  16. Integration between point-of-care cardiac markers in an emergency/cardiology department and the central laboratory: methodological and preliminary clinical evaluation
  17. Controlled storage conditions prolong stability of biochemical components in whole blood
  18. Poor knowledge and faulty thinking regarding hemolysis and potassium elevation
  19. Delayed effects of short-term transdermal application of 7-oxo-dehydroepiandrosterone on its metabolites, some hormonal steroids and relevant proteohormones in healthy male volunteers
  20. Evaluation of a novel semi-automated HPLC procedure for whole blood cyclosporin A confirms equivalence to adjusted monoclonal values from Abbott TDx
  21. Evaluation of the Bio-Rad VARIANT™ II HbA 2/HbA 1C Dual Program for measurement of hemoglobin concentrations and detection of variants
  22. Interferences in coagulation tests – evaluation of the 570-nm method on the Dade Behring BCS analyser
  23. No evidence for involvement of the human inducible nitric oxide synthase gene in susceptibility to coronary artery disease
  24. National survey on the use of measurement of cholinesterase activity in serum
Heruntergeladen am 29.10.2025 von https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2005.040/html
Button zum nach oben scrollen